Hello, everyone, and how are you today? A glorious sun is shining over the Pharmalot corporate campus, where we are hoping our redesign finally takes hold. We realize there have been various problems this week and ask that you please let us know if you encounter any difficulties or have questions - accessing the site, clicking on links, finding archived stories or anything else. We will respond and you can write us pharmalot@gmail.com Change, as you know, can be challenging. Meanwhile, the time has come to move ahead. So here are a few items of interest. Hope your day goes well and thanks for your patience...
Pfizer To Raze Old R&D HQ In Connecticut (The Day)
Compounder Recall More Extensive Than Thought (Boston Globe)
Indian Court To Decide Novartis Gleevec Patent On April 1 (Business Today)
FDA Lifts Import Alert On Aurobindo Facility (Economic Times)
Merck Lawyer Did Not Defame Contractor (Legal Intelligencer)
Drugs Cost Least At Costco, Most At CVS: Study (Reuters)
EC Gives Conditional OK To Pfizer Leukemia Drug (Pharma Times)
AstraZeneca Chases RNA Technology (Bloomberg News)
FDA Reviews Merck Allergy Tablet (Associated Press)
Taiwan To Open Drug Regulation And Training Center (Taiwan Today)
EDITOR'S NOTE: Please check this post for additional stories during the day
morning coffee pic thx to chichacha on flickr